понедельник, 23 января 2017 г.

We're in the year of the biotech buyout, and here are five prime targets

We're in the year of the biotech buyout, and here are five prime targets


If Princess Leia were a biotechnology investor, she'd be chanting: "Help me, mergers and acquisitions, you're my only hope." This little snippet of Wall Street gallows humor comes from Baird biotech analyst Brian Skorney - his stab at taking some of the edge off the sturm und drang that investors feel about a sector that just keeps getting pounded by concerns about politicians whacking drug prices.



from Biotech News